Louis, D. N., Perry, A. & Wesseling, P. The 2021 WHO classification of tumors of the central nervous system: a summary. Neuro. Oncol. 23, 1231–1251 (2021.
Miller, K. D. et al. Brain and other central nervous system tumor statistics, 2021. CA Cancer J. Clin. 71, 381–406 (2021).
Ye, Z. et al. Targeting microglial metabolic rewiring synergizes with immune-checkpoint blockade therapy for glioblastoma. Cancer Discov. 13, 974–1001 (2023).
Ostrom, Q. T. et al. CBTRUS Statistical Report: primary brain and other central nervous system tumors diagnosed in the United States in 2015–2019. Neuro. Oncol. 24, v1–v95 (2022).
Tan, A. C., Ashley, D. M. & Lopez, G. Y. Management of glioblastoma: state of the art and future directions. CA Cancer J. Clin. 70, 299–312 (2020).
Lathia, J. D., Mack, S. C., Mulkearns-Hubert, E. E., Valentim, C. L. & Rich, J. N. Cancer stem cells in glioblastoma. Genes Dev. 29, 1203–1217 (2015).
Prager, B. C., Xie, Q., Bao, S. & Rich, J. N. Cancer stem cells: the architects of the tumor ecosystem. Cell Stem Cell 24, 41–53 (2019).
Lan, X. et al. Fate mapping of human glioblastoma reveals an invariant stem cell hierarchy. Nature 549, 227–232 (2017).
Berg, T. J. & Marques, C. The irradiated brain microenvironment supports glioma stemness and survival via astrocyte-derived transglutaminase 2. Cancer Res. 81, 2101–2115 (2021).
Dapash, M., Hou, D., Castro, B., Lee-Chang, C. & Lesniak, M. S. The interplay between glioblastoma and its microenvironment. Cells 10, 2257 (2021).
Hernandez, A. & Domenech, M. Glioblastoma: relationship between metabolism and immunosuppressive microenvironment. Cells 10, 3529 (2021).
Flint, T. R., Fearon, D. T. & Janowitz, T. Connecting the metabolic and immune responses to cancer. Trends Mol. Med. 23, 451–464 (2017).
Vilbois, S., Xu, Y. & Ho, P. C. Metabolic interplay: tumor macrophages and regulatory T cells. Trends Cancer 10, 242–255 (2024).
Xia, L. et al. The cancer metabolic reprogramming and immune response. Mol. Cancer 20, 28 (2021).
Khan, F. et al. Macrophages and microglia in glioblastoma: heterogeneity, plasticity, and therapy. J. Clin. Invest. 133, e163446 (2023).
Xuan, W., Lesniak, M. S., James, C. D., Heimberger, A. B. & Chen, P. Context-dependent glioblastoma-macrophage/microglia symbiosis and associated mechanisms. Trends Immunol. 42, 280–292 (2021).
Certo, M., Tsai, C. H., Pucino, V., Ho, P. C. & Mauro, C. Lactate modulation of immune responses in inflammatory versus tumour microenvironments. Nat. Rev. Immunol. 21, 151–161 (2021).
Vander Heiden, M. G., Cantley, L. C. & Thompson, C. B. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 324, 1029–1033 (2009).
Zhang, D. et al. Metabolic regulation of gene expression by histone lactylation. Nature 574, 575–580 (2019).
Li, X. et al. Lactate metabolism in human health and disease. Signal Transduct. Target Ther. 7, 305 (2022).
Fan, M. & Yang, K. Lactate promotes endothelial-to-mesenchymal transition via Snail1 lactylation after myocardial infarction. Sci. Adv. 9, eadc9465 (2023).
Li, Z. et al. Lactate shuttling links histone lactylation to adult hippocampal neurogenesis in mice. Dev. Cell 60, 1182–1198.e1188 (2025).
Qian, Y. et al. MCT4-dependent lactate secretion suppresses antitumor immunity in LKB1-deficient lung adenocarcinoma. Cancer Cell 41, 1363–1380.e1367 (2023).
Colegio, O. R. et al. Functional polarization of tumour-associated macrophages by tumour- derived lactic acid. Nature 513, 559–563 (2014).
Abad, E., Graifer, D. & Lyakhovich, A. DNA damage response and resistance of cancer stem cells. Cancer Lett. 474, 106–117 (2020).
Bao, S. et al. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 444, 756–760 (2006).
Aleksandrov, R., Hristova, R., Stoynov, S. & Gospodinov, A. The chromatin response to double-strand DNA breaks and their repair. Cells 9, 1853 (2020).
Callen, E. et al. 53BP1 mediates productive and mutagenic DNA repair through distinct phosphoprotein interactions. Cell 153, 1266–1280 (2013).
Xu, G. et al. REV7 counteracts DNA double-strand break resection and affects PARP inhibition. Nature 521, 541–544 (2015).
Chen, Y. et al. Metabolic regulation of homologous recombination repair by MRE11 lactylation. Cell 187, 294–311.e221 (2024).
Chen, H. et al. NBS1 lactylation is required for efficient DNA repair and chemotherapy resistance. Nature 631, 663–669 (2024).
Liu, X. et al. Activation of GPR81 by lactate drives tumour-induced cachexia. Nat. Metab. 6, 708–723 (2024).
Mack, S. C. et al. Chromatin landscapes reveal developmentally encoded transcriptional states that define human glioblastoma. J. Exp. Med. 216, 1071–1090 (2019).
Al Emam, A., Arbon, D., Jeeves, M. & Kysela, B. Ku70 N-terminal lysines acetylation/deacetylation is required for radiation-induced DNA-double strand breaks repair. Neoplasma 65, 708–719 (2018).
Tubbs, A. & Nussenzweig, A. Endogenous DNA damage as a source of genomic instability in cancer. Cell 168, 644–656 (2017).
Tang, M. & Chen, G. SMYD2 inhibition-mediated hypomethylation of Ku70 contributes to impaired nonhomologous end joining repair and antitumor immunity. Sci. Adv. 9, eade6624 (2023).
Li, Z., Sun, C. & Qin, Z. Metabolic reprogramming of cancer-associated fibroblasts and its effect on cancer cell reprogramming. Theranostics 11, 8322–8336 (2021).
Wang, H., Franco, F. & Ho, P. C. Metabolic regulation of Treg in cancer: opportunities for immunotherapy. Trends Cancer 3, 583–592 (2017).
Heuser, C., Renner, K., Kreutz, M. & Gattinoni, L. Targeting lactate metabolism for cancer immunotherapy—a matter of precision. Semin Cancer Biol. 88, 32–45 (2023).
Reinfeld, B. I. & Madden, M. Z. Cell-programmed nutrient partitioning in the tumour microenvironment. Nature 593, 282–288 (2021).
Felmlee, M. A., Jones, R. S., Rodriguez-Cruz, V., Follman, K. E. & Morris, M. E. Monocarboxylate transporters (SLC16): function, regulation, and role in health and disease. Pharm. Rev. 72, 466–485 (2020).
Park, S. J. et al. An overview of MCT1 and MCT4 in GBM: small molecule transporters with large implications. Am. J. Cancer Res 8, 1967–1976 (2018).
Floch, R. L. et al. CD147 subunit of lactate/H+ symporters MCT1 and hypoxia-inducible MCT4 is critical for energetics and growth of glycolytic tumors. Proc. Natl Acad. Sci. USA 108, 16663–16668 (2011).
Sattler, B. & Kranz, M. Preclinical incorporation dosimetry of [18F]FACH-a novel 18F-labeled MCT1/MCT4 lactate transporter inhibitor for imaging cancer metabolism with PET. Molecules 25, 2024 (2020).
Li, G. et al. Glycometabolic reprogramming-induced XRCC1 lactylation confers therapeutic resistance in ALDH1A3-overexpressing glioblastoma. Cell Metab. 36, 1696–1710.e1610 (2024).
Quinet, A., Tirman, S., Cybulla, E., Meroni, A. & Vindigni, A. To skip or not to skip: choosing repriming to tolerate DNA damage. Mol. Cell 81, 649–658 (2021).
Weinstock, D. M., Richardson, C. A., Elliott, B. & Jasin, M. Modeling oncogenic translocations: distinct roles for double-strand break repair pathways in translocation formation in mammalian cells. DNA Repair (Amst.) 5, 1065–1074 (2006).
Zhao, B., Rothenberg, E. & Ramsden, D. A. The molecular basis and disease relevance of non-homologous DNA end joining. Nat. Rev. Mol. Cell Biol. 21, 765–781 (2020).
Woodbine, L., Gennery, A. R. & Jeggo, P. A. The clinical impact of deficiency in DNA non-homologous end-joining. DNA Repair (Amst.) 16, 84–96 (2014).
Kaneda, M. M. et al. PI3Kgamma is a molecular switch that controls immune suppression. Nature 539, 437–442 (2016).
Qiao, T. et al. Inhibition of LDH-A by oxamate enhances the efficacy of anti-PD-1 treatment in an NSCLC humanized mouse model. Front Oncol. 11, 632364 (2021).
Renner, K. et al. Restricting glycolysis preserves T cell effector functions and augments checkpoint therapy. Cell Rep. 29, 135–150.e139 (2019).
Vander Linden, C. et al. Therapy-induced DNA methylation inactivates MCT1 and renders tumor cells vulnerable to MCT4 inhibition. Cell Rep. 35, 109202 (2021).
Beloueche-Babari, M. & Casals Galobart, T. Monocarboxylate transporter 1 blockade with AZD3965 inhibits lipid biosynthesis and increases tumour immune cell infiltration. Br. J. Cancer 122, 895–903 (2020).
Flavahan, W. A. et al. Brain tumor initiating cells adapt to restricted nutrition through preferential glucose uptake. Nat. Neurosci. 16, 1373–1382 (2013).
Hu, Y. & Smyth, G. K. ELDA: extreme limiting dilution analysis for comparing depleted and enriched populations in stem cell and other assays. J. Immunol. Methods 347, 70–78 (2009).
Li, B. et al. Microbiota depletion impairs thermogenesis of brown adipose tissue and browning of white adipose tissue. Cell Rep. 26, 2720–2737.e2725 (2019).
Zhao, F., Kim, W. & Gao, H. ASTE1 promotes shieldin-complex-mediated DNA repair by attenuating end resection. Nat. Cell Biol. 23, 894–904 (2021).
Ying, W., Cheruku, P. S., Bazer, F. W., Safe, S. H. & Zhou, B. Investigation of macrophage polarization using bone marrow derived macrophages. J. Vis. Exp. 23, 50323 (2013).
Patro, R., Duggal, G., Love, M. I., Irizarry, R. A. & Kingsford, C. Salmon provides fast and bias-aware quantification of transcript expression. Nat. Methods 14, 417–419 (2017).
Soneson, C., Love, M. I. & Robinson, M. D. Differential analyses for RNA-seq: transcript-level estimates improve gene-level inferences. F1000Res 4, 1521 (2015).
Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).
McGinnis, C. S., Murrow, L. M. & Gartner, Z. J. DoubletFinder: doublet detection in single-cell RNA sequencing data using artificial nearest neighbors. Cell Syst. 8, 329–337.e324 (2019).
Butler, A., Hoffman, P., Smibert, P., Papalexi, E. & Satija, R. Integrating single-cell transcriptomic data across different conditions, technologies, and species. Nat. Biotechnol. 36, 411–420 (2018).
Korsunsky, I., Millard, N. & Fan, J. Fast, sensitive and accurate integration of single-cell data with Harmony. Nat. Methods 16, 1289–1296 (2019).
Aibar, S. & Gonzalez-Blas, C. B. SCENIC: single-cell regulatory network inference and clustering. Nat. Methods 14, 1083–1086 (2017).
Ravi, V. M. et al. Spatially resolved multi-omics deciphers bidirectional tumor-host interdependence in glioblastoma. Cancer Cell 40, 639–655.e613 (2022).
